Table of Contents Author Guidelines Submit a Manuscript
Infectious Diseases in Obstetrics and Gynecology
Volume 2017, Article ID 8572065, 7 pages
https://doi.org/10.1155/2017/8572065
Research Article

Prevalence of High-Risk Genotypes of Human Papillomavirus: Women Diagnosed with Premalignant and Malignant Pap Smear Tests in Southern Ecuador

1Departamento de Ciencias de la Salud, Sección Genética Humana, Microbiología y Bioquímica Clínica, Universidad Técnica Particular de Loja, Loja, Ecuador
2Sociedad de Lucha Contra el Cáncer, Hospital SOLCA Núcleo de Loja, Loja, Ecuador

Correspondence should be addressed to Paola Dalgo Aguilar; ce.ude.lptu@ogladxp

Received 2 March 2017; Accepted 23 May 2017; Published 22 June 2017

Academic Editor: Diane M. Harper

Copyright © 2017 Paola Dalgo Aguilar et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. “Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11 [Internet],” International Agency for Research on Cancer, http://globocan.iarc.fr.
  2. INEC, “Ecuador: Instituto nacional de estadísticas y censos,” http://www.inec.gob.ec/home.
  3. H. Garrido and E. Yunga, Escuela de medicina UTPL, colegio medico de, Escuela de medicina UTPL, colegio medico de Loja, 2010.
  4. G. Shen, J. Cheng, Y. Wang et al., “Viral DNA load of high-risk human papilloma virus is closely associated with the grade of cervical lesions,” Int J Exp Med, vol. 7, no. 12, pp. 5826–5831, 2014. View at Google Scholar
  5. Y.-C. Tu, H.-H. Wang, Y.-J. Lin, and T.-F. Chan, “HPV Knowledge and Factors Associated with Intention to Use Condoms for Reducing HPV Infection Risk among Adolescent Women in Taiwan,” Women and Health, vol. 55, no. 2, pp. 187–202, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. G. M. Clifford, J. S. Smith, M. Plummer, N. Muñoz, and S. Franceschi, “Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis,” British Journal of Cancer, vol. 88, no. 1, pp. 63–73, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Salcedo, P. Pina-Sanchez, V. Vallejo-Ruiz et al., “Human papillomavirus genotypes among females in Mexico: A study from the Mexican Institute for Social Security,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 23, pp. 10061–10066, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. J. G. Baseman and L. A. Koutsky, “The epidemiology of human papillomavirus infections,” Journal of Clinical Virology, vol. 32, pp. 16–24, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Léniz Martelli, V. Van De Wyngard, M. Lagos, M. I. Barriga, K. Puschel Illanes, and C. Ferreccio Readi, “Early detection of cervical cancer in Chile: Time for change,” Revista Medica de Chile, vol. 142, no. 8, pp. 1047–1055, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. X.-C. Wang, L.-Q. Sun, L. Ma et al., “Prevalence and genotype distribution of human papillomavirus among women from Henan, China,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 17, pp. 7333–7336, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. M. L. T. Cossio, L. F. Giesen, G. Araya et al., “Papiloma Virus Humano,” Sexologφa Medica, no. 2, pp. 81–87, 2012. View at Google Scholar
  12. W. Silva-Caso, M. Olivera-Irazábal, P. León-Álvarez et al., “Identification of human papillomavirus as a preventive strategy for cervical cancer in asymptomatic women in the Peruvian Andes,” Asian Pacific Journal of Tropical Medicine, vol. 7, no. 1, pp. S121–S126, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. F. X. Bosch, A. N. Burchell, M. Schiffman et al., “Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia,” Vaccine, vol. 26, no. 10, pp. K1–K16, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Zaridah, “MOG UKM. A review of cervical cancer research in Malaysia,” Med J Malaysia, August 2014. View at Google Scholar
  15. N. Muñoz, X. Castellsagué, A. B. de González, and L. Gissman, “Chapter 1: HPV in the etiology of human cancer,” Vaccine, vol. 24, supplement 3, pp. S1–S10, 2006. View at Publisher · View at Google Scholar
  16. F. X. Bosch, A. Lorincz, N. Muñoz, C. J. L. M. Meijer, and K. V. Shah, “The causal relation between human papillomavirus and cervical cancer,” Journal of Clinical Pathology, vol. 55, no. 4, pp. 244–265, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Silva, D. León, P. Brebi et al., “Diagnóstico de la infección por virus papiloma humano en el hombre,” Rev Chil Infectol, vol. 30, no. 2, pp. 186–192, 2013. View at Publisher · View at Google Scholar
  18. N. Berthet, M. Falguiéres, C. Filippone et al., “Resequencing microarray technology for genotyping human papillomavirus in cervical smears,” PLoS ONE, vol. 9, no. 11, Article ID e109301, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. J. López, G. Ili GC, MP. Brebi et al., “Detección y tipificación de virus papiloma humano en lesiones preneoplásicas de cuello uterino,” Rev Med Chil, vol. 138, no. 11, pp. 1343–1350, 2010. View at Google Scholar
  20. G. Hoste, K. Vossaert, W. Poppe et al., “The Clinical Role of HPV Testing in Primary and Secondary Cervical Cancer Screening,” Obstet Gynecol Int, Article ID 610373, p. 2013, 2013. View at Google Scholar
  21. Z. De Guglielmo, A. Rodríguez, M. Ávila et al., “Virus de papiloma humano y factores de riesgo,” Rev Oncol Y Hematol Venez, vol. 22, no. 1, pp. 32–38, 2010, http://www.scielo.org.ve/pdf/rvo/v22n1/art04.pdf. View at Google Scholar
  22. M. Jacobs V, PJ. Snijders, TJ. Helmerhorst et al., “PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes,” J Clin Microbiol, vol. 35, no. 3, p. 791, 1997. View at Google Scholar
  23. A. Alba, M. Cararach, and C. Rodriguez-Cerdeira, “The Human Papillomavirus (HPV) in Human Pathology: Description, Pathogenesis, Oncogenic Role, Epidemiology and Detection Techniques,” The Open Dermatology Journal, vol. 3, no. 2, pp. 90–102, 2009. View at Publisher · View at Google Scholar
  24. E. M. Burd, “Human papillomavirus and cervical cancer,” Clinical Microbiology Reviews, vol. 16, no. 1, pp. 1–17, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Srivastava, UP. Shahi, A. Dibya et al., “Distribution of HPV Genotypes and Involvement of Risk Factors in Cervical Lesions and Invasive Cervical Cancer: A Study in an Indian Population,” International Journal of Molecular and Cellular Medicine, vol. 3, pp. 61–73, 2014. View at Google Scholar
  26. S. De Sanjose, WG. Quint, L. Alemany et al., “Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study,” Lancet Oncol, vol. 11, no. 11, pp. 1048–1056, 2010. View at Google Scholar
  27. R. Konno, H. Yoshikawa, M. Okutani et al., “Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical intraepithelial neoplasia and cervical infection in young Japanese women: Open follow-up of a randomized clinical trial up to 4 years post-vaccination,” Human Vaccines and Immunotherapeutics, vol. 10, no. 7, pp. 1781–1794, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. FE. Campos, “Factores Asociados a Lesiones Cervicales O Presencia Del Virus Del Papiloma Humano En Dos Poblaciones De Factors Associated To Cervical Lesions or Presence of Human Papilloma Virus in Two Populations of Students From Lima,” Revista Peruana de Medicina Experimental y Salud Pública, vol. 24, no. 3, pp. 234–239, 2007. View at Google Scholar
  29. M. J. Khan, P. E. Castle, A. T. Lorincz et al., “The elevated 10-Year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice,” Journal of the National Cancer Institute, vol. 97, no. 14, pp. 1072–1079, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. A. C. Munk, I. T. Ovestad, E. Gudlaugsson et al., “Consistent condom use increases spontaneous regression in high-risk non-HPV16 but not in HPV16 CIN2-3 lesions, a prospective population-based cohort study,” Infect Agent Cancer.
  31. I. Garcés, D. C. Rubio, and I. C. Scarinci, “Factores asociados con el tamizaje de cáncer de cuello uterino en mujeres de nivel socioeconómico medio y bajo en Bogotá,” Revista Facultad Nacional de Salud Pública, vol. 30, no. 1, pp. 7–16, 2012. View at Google Scholar
  32. F. González-Andrade and D. Sánchez, “HPV genotyping in anogenital abnormal samples of Ecuadorian women,” Cancer Biomarkers, vol. 5, no. 4-5, pp. 225–232, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. L. Mejía, D. Muñoz, G. Trueba, L. Tinoco, and S. Zapata, “Prevalence of human papillomavirus types in cervical cancerous and precancerous lesions of Ecuadorian women,” Journal of Medical Virology, vol. 88, no. 1, pp. 144–152, 2016. View at Publisher · View at Google Scholar · View at Scopus
  34. V. Cabrera J, H. Cárdenas O, and C. Campoverde M, “Prevalencia de genotipos del papiloma virus humano en mujeres de la provincia del Azual de Ecuador,” Maskana, vol. 6, no. 1, pp. 79–93, 2015. View at Google Scholar
  35. C. R. Brown, M. L. Leon, K. Muñoz et al., “Human papillomavirus infection and its association with cervical dysplasia in Ecuadorian women attending a private cancer screening clinic,” Brazilian Journal of Medical and Biological Research, vol. 42, no. 7, pp. 629–636, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. L. Bruni, M. Diaz, X. Castellsagué, E. Ferrer, F. X. Bosch, and S. De Sanjosé, “Cervical human papillomavirus prevalence in 5 continents: Meta-analysis of 1 million women with normal cytological findings,” Journal of Infectious Diseases, vol. 202, no. 12, pp. 1789–1799, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Ciapponi, A. Bardach, D. Glujovsky, L. Gibbons, and M. A. Picconi, “Type-specific HPV prevalence in cervical cancer and high-grade lesions in Latin America and the Caribbean: Systematic review and meta-analysis,” PLoS ONE, vol. 6, no. 10, Article ID e25493, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. J. Canul Canche, I. Rosado López, NG. Suárez et al., “High prevalence and low E6 genetic variability of human papillomavirus 58 in women with cervical cancer and precursor lesions in Southeast Mexico,” Mem Inst Oswaldo Cruz, vol. 105, no. 2, pp. 144–148, 2010. View at Google Scholar
  39. FH. Montoya, MM. Ramírez, MM. Morán et al., “Detección de Papilomavirus Humano tipos 16, 18, 35 y 58 en cáncer cervicouterino y lesiones escamosas intraepiteliales de alto grado en el occidente de México: correlación clínico-molecular: correlación clínico-molecular,” Ginecol Obs Mex, vol. 69, no. 4, pp. 137–142, 2001. View at Google Scholar
  40. M. L. Tornesello, L. Buonaguro, S. Izzo et al., “A pilot study on the distribution of human papillomavirus genotypes and HPV-16 variants in cervical neoplastic lesions from Ecuadorian women,” Journal of Medical Virology, vol. 80, no. 11, pp. 1959–1965, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. G. D. García Muentes, L. K. García Rodríguez, R. I. Burgos Galarraga, F. Almeida Carpio, and J. C. Ruiz Cabezas, “Genotypes distribution of human papillomavirus in cervical samples of Ecuadorian women,” Revista Brasileira de Epidemiologia, vol. 19, no. 1, pp. 160–166, 2016, http://www.ncbi.nlm.nih.gov/pubmed/27167657. View at Publisher · View at Google Scholar
  42. G. M. Clifford, J. S. Smith, T. Aguado, and S. Franceschi, “Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: A meta-analysis,” British Journal of Cancer, vol. 89, no. 1, pp. 101–105, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. A. M. Johnson, C. H. Mercer, S. Beddows et al., “Epidemiology of, and behavioural risk factors for, sexually transmitted human papillomavirus infection in men and women in Britain,” Sex Transm Infect [Internet], vol. 88, no. 3, pp. 212–217, 2012, http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3308471&tool=pmcentrez&rendertype=abstract. View at Google Scholar
  44. RL. Winer, JP. Hughes, Q. Feng et al., NIH Public Access. Sex Transm Dis, vol. 10, no. 1, p. 54, 2013.
  45. K. Wellings, M. Collumbien, E. Slaymaker et al., “Sexual behaviour in context: a global perspective,” Lancet, vol. 368, no. 9548, pp. 1706–1728, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. R. L. Winer, J. P. Hughes, Q. Feng et al., “Condom use and the risk of genital human papillomavirus infection in young women,” New England Journal of Medicine, vol. 354, no. 25, pp. 2645–2654, 2006. View at Publisher · View at Google Scholar · View at Scopus